Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Exercise Tolerance | 24 | 2024 | 836 | 4.420 |
Why?
|
Exercise Test | 37 | 2024 | 2129 | 3.140 |
Why?
|
Hypertension, Pulmonary | 21 | 2024 | 1580 | 2.390 |
Why?
|
Fatigue Syndrome, Chronic | 4 | 2023 | 215 | 2.310 |
Why?
|
Exercise | 40 | 2023 | 5884 | 2.160 |
Why?
|
Vascular Resistance | 12 | 2021 | 933 | 1.440 |
Why?
|
Pulmonary Wedge Pressure | 8 | 2021 | 273 | 1.170 |
Why?
|
Anaerobic Threshold | 5 | 2019 | 51 | 1.130 |
Why?
|
Dyspnea | 9 | 2021 | 1347 | 1.090 |
Why?
|
Hemodynamics | 12 | 2021 | 4168 | 0.960 |
Why?
|
Oxygen Consumption | 18 | 2024 | 1863 | 0.950 |
Why?
|
Cardiac Output | 9 | 2021 | 837 | 0.930 |
Why?
|
Pulmonary Artery | 13 | 2021 | 1938 | 0.890 |
Why?
|
Postural Orthostatic Tachycardia Syndrome | 4 | 2024 | 53 | 0.780 |
Why?
|
Ventricular Dysfunction, Right | 4 | 2021 | 628 | 0.720 |
Why?
|
Pulmonary Ventilation | 9 | 2019 | 372 | 0.680 |
Why?
|
Ventricular Function | 2 | 2018 | 406 | 0.670 |
Why?
|
Pulmonary Gas Exchange | 12 | 2020 | 379 | 0.640 |
Why?
|
Ventricular Function, Right | 6 | 2024 | 618 | 0.620 |
Why?
|
Atrial Function | 1 | 2018 | 99 | 0.600 |
Why?
|
Pulmonary Circulation | 8 | 2019 | 743 | 0.600 |
Why?
|
Connective Tissue Diseases | 1 | 2021 | 285 | 0.590 |
Why?
|
Stroke Volume | 16 | 2021 | 5497 | 0.550 |
Why?
|
Respiratory Mechanics | 9 | 2020 | 699 | 0.550 |
Why?
|
Microvessels | 1 | 2021 | 576 | 0.540 |
Why?
|
Lung Diseases, Obstructive | 5 | 1998 | 308 | 0.510 |
Why?
|
Muscle, Skeletal | 14 | 2013 | 4946 | 0.480 |
Why?
|
Lung Diseases | 4 | 2021 | 1909 | 0.470 |
Why?
|
Physical Exertion | 5 | 2014 | 667 | 0.450 |
Why?
|
Respiration Disorders | 2 | 2014 | 367 | 0.440 |
Why?
|
Ventricular Pressure | 4 | 2021 | 210 | 0.440 |
Why?
|
Orthostatic Intolerance | 3 | 2022 | 23 | 0.430 |
Why?
|
Arteriovenous Fistula | 1 | 2016 | 319 | 0.420 |
Why?
|
Myocardial Contraction | 1 | 2018 | 1517 | 0.420 |
Why?
|
Alveolitis, Extrinsic Allergic | 2 | 2018 | 63 | 0.390 |
Why?
|
Lung Diseases, Interstitial | 1 | 2020 | 917 | 0.370 |
Why?
|
Heart Failure | 12 | 2024 | 11674 | 0.360 |
Why?
|
Chemoreceptor Cells | 4 | 2001 | 89 | 0.340 |
Why?
|
Lung | 8 | 2024 | 9995 | 0.340 |
Why?
|
Catheterization, Peripheral | 1 | 2013 | 342 | 0.330 |
Why?
|
Phosphocreatine | 7 | 2011 | 261 | 0.330 |
Why?
|
Heart Rate | 8 | 2022 | 4198 | 0.300 |
Why?
|
Oxygen | 7 | 2022 | 4228 | 0.300 |
Why?
|
Ultrasonography | 3 | 2024 | 5970 | 0.280 |
Why?
|
Respiration | 6 | 2013 | 1657 | 0.270 |
Why?
|
Middle Aged | 50 | 2024 | 220826 | 0.260 |
Why?
|
Heart Ventricles | 5 | 2021 | 3816 | 0.260 |
Why?
|
Hydrotherapy | 1 | 2005 | 6 | 0.250 |
Why?
|
Mycobacterium avium Complex | 1 | 2005 | 59 | 0.250 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2005 | 76 | 0.240 |
Why?
|
Male | 67 | 2024 | 360736 | 0.240 |
Why?
|
Female | 67 | 2024 | 392581 | 0.230 |
Why?
|
Humans | 93 | 2024 | 761423 | 0.230 |
Why?
|
Penicillanic Acid | 1 | 2024 | 42 | 0.230 |
Why?
|
Ventriculography, First-Pass | 3 | 2008 | 20 | 0.220 |
Why?
|
Aged | 29 | 2024 | 169235 | 0.220 |
Why?
|
Lactates | 4 | 1998 | 405 | 0.220 |
Why?
|
Lung Transplantation | 6 | 2002 | 1309 | 0.220 |
Why?
|
Blood Pressure | 7 | 2022 | 8487 | 0.210 |
Why?
|
Lung Abscess | 2 | 2005 | 40 | 0.210 |
Why?
|
Carbon Dioxide | 5 | 2011 | 1146 | 0.210 |
Why?
|
Pyridostigmine Bromide | 1 | 2022 | 32 | 0.210 |
Why?
|
Mitochondria, Muscle | 5 | 2011 | 172 | 0.200 |
Why?
|
Perfusion Imaging | 2 | 2022 | 196 | 0.190 |
Why?
|
Posture | 2 | 2017 | 956 | 0.180 |
Why?
|
Sulfones | 4 | 2011 | 447 | 0.170 |
Why?
|
Fontan Procedure | 3 | 2014 | 797 | 0.170 |
Why?
|
Systole | 5 | 2021 | 937 | 0.170 |
Why?
|
Fatigue | 3 | 2023 | 1551 | 0.160 |
Why?
|
Respiratory System Agents | 1 | 1998 | 30 | 0.160 |
Why?
|
Elasticity | 1 | 2021 | 655 | 0.160 |
Why?
|
Rest | 4 | 2016 | 919 | 0.160 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 3204 | 0.160 |
Why?
|
Helium | 1 | 1998 | 119 | 0.160 |
Why?
|
Adult | 37 | 2024 | 221148 | 0.150 |
Why?
|
ROC Curve | 4 | 2018 | 3580 | 0.150 |
Why?
|
Intracellular Fluid | 1 | 1998 | 201 | 0.150 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2017 | 86 | 0.140 |
Why?
|
Echocardiography, Stress | 1 | 2017 | 134 | 0.130 |
Why?
|
Obesity | 2 | 2018 | 12938 | 0.130 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 322 | 0.130 |
Why?
|
Reflex | 1 | 1998 | 376 | 0.130 |
Why?
|
Extracellular Space | 1 | 1998 | 563 | 0.130 |
Why?
|
Oxygen Inhalation Therapy | 1 | 1998 | 410 | 0.120 |
Why?
|
Magnetic Resonance Spectroscopy | 10 | 2010 | 3769 | 0.120 |
Why?
|
Vascular Diseases | 2 | 2021 | 1161 | 0.120 |
Why?
|
Piperazines | 4 | 2011 | 2523 | 0.120 |
Why?
|
Iron-Sulfur Proteins | 1 | 2015 | 83 | 0.120 |
Why?
|
Cheyne-Stokes Respiration | 1 | 2014 | 38 | 0.120 |
Why?
|
Sulfur | 1 | 2015 | 162 | 0.120 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2017 | 261 | 0.120 |
Why?
|
Bicycling | 1 | 2015 | 177 | 0.120 |
Why?
|
Forced Expiratory Volume | 3 | 2013 | 1812 | 0.110 |
Why?
|
Monitoring, Physiologic | 1 | 2021 | 1780 | 0.110 |
Why?
|
Echocardiography | 5 | 2021 | 4991 | 0.110 |
Why?
|
Ventricular Function, Left | 2 | 2017 | 3879 | 0.110 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2011 | 2119 | 0.110 |
Why?
|
Echocardiography, Doppler | 1 | 2017 | 898 | 0.110 |
Why?
|
Inflammation Mediators | 1 | 2022 | 1886 | 0.110 |
Why?
|
Heart | 2 | 2012 | 4405 | 0.100 |
Why?
|
Physical Endurance | 2 | 2013 | 366 | 0.100 |
Why?
|
Phenotype | 3 | 2021 | 16606 | 0.100 |
Why?
|
Vasodilator Agents | 3 | 2020 | 973 | 0.100 |
Why?
|
Postpoliomyelitis Syndrome | 1 | 1992 | 7 | 0.100 |
Why?
|
Coronary Circulation | 1 | 2018 | 1569 | 0.100 |
Why?
|
Dextroamphetamine | 1 | 2012 | 134 | 0.100 |
Why?
|
Pulmonary Edema | 2 | 2024 | 409 | 0.100 |
Why?
|
Spirometry | 2 | 2014 | 928 | 0.100 |
Why?
|
Feasibility Studies | 2 | 2021 | 5246 | 0.100 |
Why?
|
Cerebrovascular Circulation | 1 | 2022 | 2727 | 0.100 |
Why?
|
Respiratory Function Tests | 4 | 2021 | 1682 | 0.090 |
Why?
|
Hydrogen-Ion Concentration | 4 | 1998 | 2498 | 0.090 |
Why?
|
Blood Gas Analysis | 3 | 2011 | 379 | 0.090 |
Why?
|
Patient Positioning | 3 | 2020 | 326 | 0.090 |
Why?
|
Tunica Media | 1 | 2010 | 112 | 0.090 |
Why?
|
Electrocardiography | 1 | 2024 | 6384 | 0.090 |
Why?
|
Insulin Resistance | 4 | 2013 | 3963 | 0.090 |
Why?
|
Pressure | 1 | 2013 | 1155 | 0.090 |
Why?
|
Ammonia | 1 | 1991 | 237 | 0.090 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 1991 | 241 | 0.090 |
Why?
|
Veins | 1 | 2014 | 768 | 0.090 |
Why?
|
Heart Failure, Systolic | 1 | 2011 | 135 | 0.090 |
Why?
|
Thoracotomy | 1 | 1991 | 367 | 0.090 |
Why?
|
Mountaineering | 1 | 2010 | 45 | 0.090 |
Why?
|
Diet, Reducing | 1 | 2013 | 485 | 0.080 |
Why?
|
Growth | 1 | 2011 | 365 | 0.080 |
Why?
|
Gated Blood-Pool Imaging | 1 | 2008 | 42 | 0.080 |
Why?
|
Altitude Sickness | 1 | 2010 | 91 | 0.080 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2014 | 1241 | 0.080 |
Why?
|
Biopsy | 1 | 2021 | 6766 | 0.080 |
Why?
|
Physical Fitness | 1 | 2013 | 739 | 0.080 |
Why?
|
Muscle Tonus | 1 | 2008 | 82 | 0.080 |
Why?
|
Tunica Intima | 1 | 2010 | 458 | 0.080 |
Why?
|
Heart Diseases | 2 | 1998 | 2785 | 0.080 |
Why?
|
Prognosis | 5 | 2024 | 29620 | 0.070 |
Why?
|
Heart Defects, Congenital | 2 | 2014 | 4696 | 0.070 |
Why?
|
Tracheostomy | 1 | 1992 | 426 | 0.070 |
Why?
|
Positive-Pressure Respiration | 1 | 1992 | 639 | 0.070 |
Why?
|
Blood | 1 | 2010 | 598 | 0.070 |
Why?
|
Lactic Acid | 4 | 2002 | 1137 | 0.070 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2021 | 793 | 0.070 |
Why?
|
MicroRNAs | 2 | 2015 | 3812 | 0.070 |
Why?
|
Stavudine | 1 | 2007 | 85 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2248 | 0.070 |
Why?
|
Predictive Value of Tests | 7 | 2020 | 15262 | 0.070 |
Why?
|
Autonomic Nervous System | 2 | 2022 | 701 | 0.070 |
Why?
|
Risk Reduction Behavior | 1 | 2013 | 1112 | 0.070 |
Why?
|
Acidosis, Lactic | 2 | 1998 | 145 | 0.070 |
Why?
|
Phosphorus | 3 | 2007 | 336 | 0.070 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2007 | 214 | 0.070 |
Why?
|
Area Under Curve | 3 | 2017 | 1638 | 0.070 |
Why?
|
Human Growth Hormone | 1 | 2010 | 638 | 0.060 |
Why?
|
Energy Metabolism | 3 | 2010 | 2881 | 0.060 |
Why?
|
Mitochondria | 2 | 2009 | 3623 | 0.060 |
Why?
|
Purines | 4 | 2011 | 605 | 0.060 |
Why?
|
Pilot Projects | 1 | 2018 | 8633 | 0.060 |
Why?
|
Muscles | 1 | 1990 | 1576 | 0.060 |
Why?
|
Pulmonary Veins | 1 | 2011 | 746 | 0.060 |
Why?
|
Reproducibility of Results | 4 | 2017 | 20093 | 0.060 |
Why?
|
Lipid Metabolism | 1 | 2013 | 1902 | 0.060 |
Why?
|
Brain Abscess | 1 | 2005 | 120 | 0.060 |
Why?
|
Remission, Spontaneous | 1 | 2005 | 384 | 0.060 |
Why?
|
Pneumonia, Aspiration | 1 | 2005 | 145 | 0.060 |
Why?
|
Carotid Artery Diseases | 1 | 2010 | 877 | 0.060 |
Why?
|
Vasoconstrictor Agents | 1 | 2008 | 654 | 0.060 |
Why?
|
Paresis | 1 | 2005 | 176 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2020 | 22168 | 0.060 |
Why?
|
Time Factors | 7 | 2017 | 39975 | 0.060 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2007 | 621 | 0.060 |
Why?
|
Athletes | 1 | 2011 | 1136 | 0.060 |
Why?
|
Activin Receptors, Type II | 1 | 2024 | 123 | 0.050 |
Why?
|
Central Nervous System Stimulants | 1 | 2012 | 1176 | 0.050 |
Why?
|
Sleep | 1 | 2019 | 4766 | 0.050 |
Why?
|
Perfusion | 1 | 2008 | 1373 | 0.050 |
Why?
|
Adaptation, Physiological | 1 | 2010 | 1301 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6485 | 0.050 |
Why?
|
Granuloma | 1 | 2005 | 327 | 0.050 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2005 | 754 | 0.050 |
Why?
|
Preoperative Care | 1 | 1991 | 2242 | 0.050 |
Why?
|
Prospective Studies | 4 | 2018 | 54415 | 0.050 |
Why?
|
Body Weight | 2 | 2010 | 4618 | 0.050 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2008 | 1491 | 0.050 |
Why?
|
Retrospective Studies | 9 | 2024 | 80582 | 0.050 |
Why?
|
Consensus | 2 | 2021 | 3122 | 0.050 |
Why?
|
Cystic Fibrosis | 2 | 2002 | 1286 | 0.050 |
Why?
|
Connecticut | 1 | 2021 | 364 | 0.050 |
Why?
|
Oxidative Phosphorylation | 2 | 2013 | 496 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2019 | 58956 | 0.040 |
Why?
|
Disasters | 1 | 2005 | 519 | 0.040 |
Why?
|
Cytochrome b Group | 1 | 1998 | 59 | 0.040 |
Why?
|
Aerobiosis | 1 | 1998 | 100 | 0.040 |
Why?
|
Phosphodiesterase 5 Inhibitors | 2 | 2011 | 103 | 0.040 |
Why?
|
Mitochondrial Myopathies | 1 | 1998 | 50 | 0.040 |
Why?
|
DNA, Mitochondrial | 2 | 2007 | 865 | 0.040 |
Why?
|
Overweight | 1 | 2009 | 2413 | 0.040 |
Why?
|
Recovery of Function | 2 | 2024 | 2977 | 0.040 |
Why?
|
United States | 7 | 2021 | 72339 | 0.040 |
Why?
|
1-Naphthylamine | 1 | 1998 | 49 | 0.040 |
Why?
|
Alkalosis | 1 | 1998 | 55 | 0.040 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 1998 | 113 | 0.040 |
Why?
|
Radiography | 1 | 2008 | 6966 | 0.040 |
Why?
|
Waiting Lists | 1 | 2002 | 765 | 0.040 |
Why?
|
Follow-Up Studies | 7 | 2021 | 39117 | 0.040 |
Why?
|
Adolescent | 11 | 2021 | 88313 | 0.040 |
Why?
|
Nitrogen | 1 | 1998 | 348 | 0.040 |
Why?
|
Acid-Base Equilibrium | 1 | 1998 | 181 | 0.040 |
Why?
|
Puberty | 2 | 2011 | 501 | 0.040 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2012 | 3704 | 0.030 |
Why?
|
Vagus Nerve | 1 | 2019 | 458 | 0.030 |
Why?
|
Diet | 1 | 1994 | 8074 | 0.030 |
Why?
|
Vital Capacity | 1 | 1998 | 970 | 0.030 |
Why?
|
Regression Analysis | 2 | 2010 | 6343 | 0.030 |
Why?
|
Sex Distribution | 1 | 2021 | 2281 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 1998 | 1156 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2024 | 3734 | 0.030 |
Why?
|
Phosphates | 2 | 1998 | 770 | 0.030 |
Why?
|
Glucose | 1 | 2007 | 4347 | 0.030 |
Why?
|
Supine Position | 1 | 2015 | 205 | 0.030 |
Why?
|
Diastole | 1 | 2016 | 782 | 0.030 |
Why?
|
Brazil | 1 | 2018 | 1230 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2018 | 15498 | 0.030 |
Why?
|
Tricuspid Valve | 1 | 2017 | 413 | 0.030 |
Why?
|
Risk Factors | 4 | 2016 | 74167 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2022 | 2133 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17912 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2011 | 1931 | 0.030 |
Why?
|
Pneumonia | 1 | 2005 | 2140 | 0.030 |
Why?
|
Homeostasis | 2 | 2011 | 3321 | 0.030 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2017 | 355 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2005 | 12970 | 0.030 |
Why?
|
Young Adult | 6 | 2019 | 59207 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 26112 | 0.020 |
Why?
|
Hypertension | 1 | 2012 | 8542 | 0.020 |
Why?
|
Cohort Studies | 4 | 2022 | 41446 | 0.020 |
Why?
|
Sodium Glutamate | 1 | 1991 | 23 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2019 | 2141 | 0.020 |
Why?
|
Mood Disorders | 1 | 1998 | 1127 | 0.020 |
Why?
|
Nontherapeutic Human Experimentation | 1 | 2010 | 22 | 0.020 |
Why?
|
Sleep Apnea Syndromes | 1 | 1998 | 975 | 0.020 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2010 | 67 | 0.020 |
Why?
|
Environment, Controlled | 1 | 2010 | 42 | 0.020 |
Why?
|
Treatment Outcome | 5 | 2024 | 64651 | 0.020 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2013 | 542 | 0.020 |
Why?
|
Dietary Carbohydrates | 1 | 1994 | 891 | 0.020 |
Why?
|
Mutation, Missense | 1 | 1998 | 2571 | 0.020 |
Why?
|
Calorimetry, Indirect | 1 | 2009 | 174 | 0.020 |
Why?
|
Pulmonary Emphysema | 1 | 1994 | 685 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 12143 | 0.020 |
Why?
|
Motor Activity | 2 | 2010 | 2711 | 0.020 |
Why?
|
Lipids | 2 | 2010 | 3340 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8832 | 0.020 |
Why?
|
Pain | 1 | 2023 | 5071 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2011 | 1179 | 0.020 |
Why?
|
Treatment Failure | 1 | 2014 | 2642 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2019 | 2574 | 0.020 |
Why?
|
Whole-Body Irradiation | 1 | 1988 | 433 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6479 | 0.020 |
Why?
|
Gonadal Steroid Hormones | 1 | 2011 | 702 | 0.020 |
Why?
|
Glycemic Index | 1 | 2009 | 396 | 0.020 |
Why?
|
Survival Analysis | 2 | 2014 | 10089 | 0.020 |
Why?
|
Pulmonary Alveoli | 1 | 2010 | 650 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10548 | 0.020 |
Why?
|
Mitral Valve | 1 | 2015 | 1471 | 0.020 |
Why?
|
Child | 5 | 2014 | 80162 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 1998 | 8179 | 0.020 |
Why?
|
Dietary Fats | 1 | 1994 | 1994 | 0.020 |
Why?
|
Survival Rate | 2 | 2017 | 12720 | 0.020 |
Why?
|
Glucose Clamp Technique | 1 | 2007 | 263 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 1998 | 2717 | 0.020 |
Why?
|
Animals | 7 | 2015 | 168441 | 0.020 |
Why?
|
Carotid Arteries | 1 | 2010 | 941 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 3 | 2005 | 20556 | 0.020 |
Why?
|
Cardiac Output, Low | 1 | 2006 | 191 | 0.020 |
Why?
|
Glycolysis | 1 | 1990 | 836 | 0.020 |
Why?
|
Quality of Life | 1 | 2007 | 13361 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2008 | 12330 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 1998 | 2897 | 0.020 |
Why?
|
Aphasia, Broca | 1 | 2005 | 52 | 0.020 |
Why?
|
Glutamine | 1 | 1988 | 577 | 0.020 |
Why?
|
Indonesia | 1 | 2005 | 128 | 0.020 |
Why?
|
Empyema, Pleural | 1 | 2005 | 61 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2011 | 1989 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2011 | 14599 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 2010 | 1737 | 0.010 |
Why?
|
Body Height | 1 | 2010 | 1570 | 0.010 |
Why?
|
Cytokines | 1 | 2019 | 7392 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2019 | 4477 | 0.010 |
Why?
|
Energy Intake | 1 | 2011 | 2134 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9320 | 0.010 |
Why?
|
Algorithms | 1 | 2004 | 14026 | 0.010 |
Why?
|
Patient Compliance | 1 | 2013 | 2690 | 0.010 |
Why?
|
Reference Values | 1 | 2010 | 4921 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21341 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2015 | 3541 | 0.010 |
Why?
|
Dyslipidemias | 1 | 2009 | 868 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2010 | 1879 | 0.010 |
Why?
|
Methotrexate | 1 | 1988 | 1718 | 0.010 |
Why?
|
Pneumothorax | 1 | 2005 | 383 | 0.010 |
Why?
|
Blood Transfusion | 1 | 1988 | 1299 | 0.010 |
Why?
|
Aging | 2 | 2011 | 8705 | 0.010 |
Why?
|
Rats | 1 | 1998 | 23742 | 0.010 |
Why?
|
Protons | 1 | 2007 | 1115 | 0.010 |
Why?
|
Heart Transplantation | 1 | 2014 | 3234 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2011 | 2637 | 0.010 |
Why?
|
Metabolomics | 1 | 2010 | 1657 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10762 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 18964 | 0.010 |
Why?
|
Radionuclide Ventriculography | 1 | 1998 | 40 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 1998 | 7409 | 0.010 |
Why?
|
Electron Transport Complex III | 1 | 1998 | 31 | 0.010 |
Why?
|
Coenzymes | 1 | 1998 | 102 | 0.010 |
Why?
|
Muscle Fatigue | 1 | 1998 | 95 | 0.010 |
Why?
|
Hospitalization | 1 | 2018 | 10718 | 0.010 |
Why?
|
Body Composition | 1 | 2007 | 2422 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2009 | 3187 | 0.010 |
Why?
|
Ubiquinone | 1 | 1998 | 183 | 0.010 |
Why?
|
Prevalence | 1 | 2014 | 15717 | 0.010 |
Why?
|
Blood Glucose | 1 | 2011 | 6391 | 0.010 |
Why?
|
Sertraline | 1 | 1998 | 209 | 0.010 |
Why?
|
Cell Line | 1 | 2010 | 15605 | 0.010 |
Why?
|
Mice | 2 | 2015 | 81509 | 0.010 |
Why?
|
Maximal Expiratory Flow-Volume Curves | 1 | 1994 | 25 | 0.010 |
Why?
|
Conserved Sequence | 1 | 1998 | 1165 | 0.010 |
Why?
|
Insulin | 1 | 2009 | 6602 | 0.010 |
Why?
|
Postoperative Complications | 1 | 1997 | 15650 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1998 | 2748 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1998 | 2179 | 0.010 |
Why?
|
Body Mass Index | 1 | 2011 | 12951 | 0.010 |
Why?
|
Dogs | 2 | 1988 | 3839 | 0.010 |
Why?
|
Age Factors | 1 | 2010 | 18400 | 0.010 |
Why?
|
Arousal | 1 | 1998 | 1166 | 0.010 |
Why?
|
Folic Acid | 1 | 1998 | 1323 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 1998 | 1887 | 0.010 |
Why?
|
Postoperative Period | 1 | 1994 | 1815 | 0.010 |
Why?
|
Boston | 1 | 2002 | 9330 | 0.010 |
Why?
|
Methionine Sulfoximine | 1 | 1988 | 12 | 0.010 |
Why?
|
Bronchoscopy | 1 | 1994 | 909 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 2002 | 12058 | 0.000 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 1988 | 75 | 0.000 |
Why?
|
Proportional Hazards Models | 1 | 2002 | 12456 | 0.000 |
Why?
|
Base Sequence | 1 | 1998 | 12450 | 0.000 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2005 | 4579 | 0.000 |
Why?
|
Glutamates | 1 | 1988 | 389 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1998 | 13449 | 0.000 |
Why?
|
Histocompatibility Testing | 1 | 1988 | 719 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1998 | 17644 | 0.000 |
Why?
|
Linear Models | 1 | 1994 | 5869 | 0.000 |
Why?
|
Neurotransmitter Agents | 1 | 1988 | 665 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 36423 | 0.000 |
Why?
|
Length of Stay | 1 | 1997 | 6422 | 0.000 |
Why?
|
Glutamic Acid | 1 | 1988 | 1176 | 0.000 |
Why?
|
Haplotypes | 1 | 1988 | 2775 | 0.000 |
Why?
|
gamma-Aminobutyric Acid | 1 | 1988 | 1140 | 0.000 |
Why?
|
Central Nervous System | 1 | 1988 | 1337 | 0.000 |
Why?
|
Transplantation, Homologous | 1 | 1988 | 4808 | 0.000 |
Why?
|
Immune Tolerance | 1 | 1988 | 2300 | 0.000 |
Why?
|
Brain | 1 | 2005 | 27107 | 0.000 |
Why?
|
Models, Biological | 1 | 1988 | 9469 | 0.000 |
Why?
|